|
Name |
Purpurquinone A
|
| Molecular Formula | C21H20O9 | |
| IUPAC Name* |
[(1S,7R,8aS)-1,8a-dihydroxy-7-methyl-6,8-dioxo-3-[(E)-prop-1-enyl]-1H-isochromen-7-yl] 2,4-dihydroxy-6-methylbenzoate
|
|
| SMILES |
C/C=C/C1=CC2=CC(=O)[C@@](C(=O)[C@]2([C@H](O1)O)O)(C)OC(=O)C3=C(C=C(C=C3C)O)O
|
|
| InChI |
InChI=1S/C21H20O9/c1-4-5-13-7-11-8-15(24)20(3,18(26)21(11,28)19(27)29-13)30-17(25)16-10(2)6-12(22)9-14(16)23/h4-9,19,22-23,27-28H,1-3H3/b5-4+/t19-,20+,21+/m0/s1
|
|
| InChIKey |
AWAFQUDYYMTSLY-QWOQCBQGSA-N
|
|
| Synonyms |
Purpurquinone A; CHEBI:69469; CHEMBL1823108; DTXSID401316955; Q27137807; (1S,7R,8aS)-1,8a-dihydroxy-7-methyl-6,8-dioxo-3-[(1E)-prop-1-en-1-yl]-6,7,8,8a-tetrahydro-1H-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate; 1333907-59-7
|
|
| CAS | 1333907-59-7 | |
| PubChem CID | 54672171 | |
| ChEMBL ID | CHEMBL1823108 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 416.4 | ALogp: | 1.8 |
| HBD: | 4 | HBA: | 9 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 151.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 30 | QED Weighted: | 0.423 |
| Caco-2 Permeability: | -5.331 | MDCK Permeability: | 0.00001860 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.992 |
| Human Intestinal Absorption (HIA): | 0.082 | 20% Bioavailability (F20%): | 0.942 |
| 30% Bioavailability (F30%): | 0.916 |
| Blood-Brain-Barrier Penetration (BBB): | 0.552 | Plasma Protein Binding (PPB): | 91.63% |
| Volume Distribution (VD): | 0.825 | Fu: | 7.40% |
| CYP1A2-inhibitor: | 0.722 | CYP1A2-substrate: | 0.827 |
| CYP2C19-inhibitor: | 0.174 | CYP2C19-substrate: | 0.361 |
| CYP2C9-inhibitor: | 0.271 | CYP2C9-substrate: | 0.301 |
| CYP2D6-inhibitor: | 0.54 | CYP2D6-substrate: | 0.091 |
| CYP3A4-inhibitor: | 0.765 | CYP3A4-substrate: | 0.785 |
| Clearance (CL): | 1.837 | Half-life (T1/2): | 0.622 |
| hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.908 |
| Drug-inuced Liver Injury (DILI): | 0.953 | AMES Toxicity: | 0.914 |
| Rat Oral Acute Toxicity: | 0.775 | Maximum Recommended Daily Dose: | 0.956 |
| Skin Sensitization: | 0.927 | Carcinogencity: | 0.792 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.352 |
| Respiratory Toxicity: | 0.845 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002606 | ![]() |
0.560 | D07MGA | ![]() |
0.270 | ||
| ENC003615 | ![]() |
0.515 | D0J2NK | ![]() |
0.267 | ||
| ENC002726 | ![]() |
0.515 | D08NQZ | ![]() |
0.262 | ||
| ENC003640 | ![]() |
0.477 | D0S0LZ | ![]() |
0.252 | ||
| ENC003304 | ![]() |
0.477 | D0R6RC | ![]() |
0.248 | ||
| ENC002131 | ![]() |
0.472 | D04AIT | ![]() |
0.243 | ||
| ENC003837 | ![]() |
0.450 | D0H1AR | ![]() |
0.242 | ||
| ENC002211 | ![]() |
0.445 | D0K8KX | ![]() |
0.239 | ||
| ENC002132 | ![]() |
0.427 | D02GAC | ![]() |
0.237 | ||
| ENC005503 | ![]() |
0.418 | D0R9WP | ![]() |
0.233 | ||